TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Conditions

• Skin and Subcutaneous Tissue Bacterial Infections

Interventions

• DRUG: TR-701 FA
• DRUG: Linezolid

Sponsor

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)